Hub is accessible on both mobile and desktop for all physicians that order a Tempus test . The platform allows easy access to Tempus test orders and results , including guideline-matched therapies , treatment resistance information , clinical trial opportunities and longitudinal tracking of biomarkers for each patient . The new features and enhancements include :

• Patient similarities : This enhanced feature allows physicians to view other Tempus patients similar to their patient . Through Hub , providers can securely request deidentified patient reports through its secure platform to get a deep understanding about treatment plans , as well as easily connect with other providers for a second opinion .

• Consults : Within the Hub mobile application , users can use Consults , Tempus ’ peer-to-peer messaging tool to easily discuss and collaborate with other physicians across institutions on complex patient cases . Consults provides instant de-identification of patient summary reports so that patient privacy is protected .

• Refresh : At any time after an initial test order , physicians can opt to ‘ refresh ’ a patient ’ s report results and receive updated therapies and clinical trials based on the latest information , rather than what was available at the time of the original order . This feature , which is currently being piloted , is designed to allow physicians to revisit a patient ’ s molecular profile findings and discover if new guidelines , therapies or clinical trials pertinent to that patient have become available .

• Tempus One updates : Tempus One now offers a ‘ Concierge ’ service embedded within Tempus One , which gives clinicians and care teams an easy way to request additional support from a Tempus team member . This high-touch feature gives users direct access to a Tempus team member to fulfill administrative requests such as supplemental testing , mobile phlebotomy , custom searches for sequenced patients by criteria , and more .

Physicians have the ability to query the Memorial Sloan Kettering Cancer Center OncoKB database to access the latest information on FDA-approved therapies and relevant biomarkers to help inform guideline-based care .

Continuously evolving to address clinical demands , Tempus One also now enables physicians to swiftly locate over 36 million citations and abstracts from PubMed ’ s biomedical literature and relevant publications .

“ Hub has continuously evolved since we initially introduced it to physicians eight years ago , and as a result of their ongoing feedback and advancements in technology , we ’ ve honed the tool so that it seamlessly offers the power of our ordering solutions for physicians in one place ,” said Ezra Cohen , MD , Chief Medical Officer of Oncology at Tempus . “ Its versatility allows for physicians to use it however they prefer – whether it is to track a test order , report on how many of their patients have a singular biomarker or discuss a unique patient case with other treating physicians .” �

52 www . intelligenthealth . tech